Walter Miller has been appointed chief financial officer at Heidelberg Pharma AG, a German oncology specialist. Mr Miller was most recently CFO of Optimapharm Group, a clinical research organisation in Croatia, where he was responsible for finance, mergers and acquisitions, and administration. Prior to this, he was CFO at Mologen AG, a developer of DNA-based medicines against cancer. He holds a degree in business administration from the University of Aachen in Germany.
Heidelberg Pharma announced the appointment on 5 May 2023.
Copyright 2023 Evernow Publishing Ltd